agilon health inc. Cash Flow Statement
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
82.39-2.33 (-2.75%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
agilon health inc. free cash flow
In fiscal 2025, agilon health inc. generated -$105.8 million of operating cash flow and spent $13.2 million on capital expenditures. That left free cash flow of -$119.0 million, a free-cash-flow margin of -2.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
agilon health inc. cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -391.35M | -260.10M | -262.80M | -106.86M | -406.79M | -60.05M | -282.74M |
| Net Income growth (YoY) | — | — | — | — | — | — | — |
| Depreciation & Amortization | 28.59M | 24.46M | 20.16M | 13.77M | 14.67M | 14.10M | 41.41M |
| Stock-Based Compensation | 49.12M | 50.66M | 69.50M | 28.38M | 292.39M | 6.69M | 5.22M |
| Change in Working Capital | 256.80M | -71.76M | -445.45M | -150.53M | -127.45M | -30.83M | 13.93M |
| Operating Cash Flow | -105.76M | -57.78M | -156.20M | -130.81M | -148.16M | -53.20M | -103.86M |
| Capital Expenditures | -13.24M | -13.25M | -15.83M | -15.43M | -6.56M | -1.77M | -2.89M |
| Investing Cash Flow | 88.61M | 139.89M | -44.02M | -444.39M | -90.51M | 22.07M | -5.06M |
| Share Repurchases | 0 | 0 | -200.00M | 0 | 0 | -6.70M | 0 |
| Debt Issued | — | — | 0 | 0 | 100.00M | 0 | 0 |
| Debt Repaid | 0 | -3.75M | -5.00M | -5.00M | -119.90M | -3.04M | -3.59M |
| Financing Cash Flow | -2.99M | -2.58M | -193.13M | 28.06M | 1.15B | 24.62M | 176.30M |
| Net Change in Cash | -20.15M | 79.53M | -393.35M | -547.14M | 915.73M | -6.52M | 67.38M |
| Free Cash Flow | -119.00M | -71.03M | -172.03M | -146.23M | -154.72M | -54.98M | -106.75M |
This table shows 7 annual periods of agilon health inc.'s cash flow statement, from FY 2025 back to FY 2019, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow AGL's reporting calendar. What is a cash flow statement?